Incretin-Pathway Peptides
Cagrilintide
An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.
5mg · 10mg · 20mg
View Details
Incretin-Pathway Peptides
Retatrutide and cagrilintide combined at equal nominal mass, sealed as a lyophilized vial for comparative research.
Research use only
RC10 is a two-component research formulation combining retatrutide and cagrilintide at equal nominal mass. It is cataloged in the incretin-pathway section alongside the other combination entries built from GLP-1, GIP, glucagon, and amylin analogues.
This entry is supplied for in-vitro comparison between the two components, analytical verification, and studies of blend compatibility. As a two-peptide blend, no single CAS number or molecular weight applies to the vial as a whole; that detail is set out per batch in the documentation.
The vial is sealed after freeze-drying and labeled with its total nominal mass of 10mg. Batch documentation is confirmed by inquiry.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | See batch documentation |
| Molecular weight | See batch documentation |
| Molecular formula | See batch documentation |
| Material class | Two-component peptide blend |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 10mg total |
| Documentation | Batch documentation confirmed on request |